Jayme Stokes, MD
Surgery · Wilmington, NCNPI 1851504336
Payments from drug & device makers
Across 142 payments — averaging $224.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$31K
- Johnson & Johnson$408
- Intra-sana Laboratories$181
- Novo Nordisk$119
- Smith+Nephew$105
- Davol Inc.$65
- plus $417 from 15 others
What the payments were for
- Speaking & faculty fees$5002%
- Travel & lodging$1,3314%
- Food & beverage$4,51314%
- Education$25,50080%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 78 | $30,562 |
| Johnson & Johnson | 13 | $408 |
| Intra-sana Laboratories | 21 | $181 |
| Novo Nordisk | 2 | $119 |
| Smith+Nephew | 5 | $105 |
| Davol Inc. | 2 | $65 |
| Endo Pharmaceuticals Inc. | 3 | $60 |
| Vertex | 2 | $53 |
| Innocoll Pharmaceuticals Limited | 2 | $41 |
| Heron Therapeutics, Inc. | 2 | $41 |
| Baxter Healthcare | 2 | $33 |
| Acell, Inc. | 1 | $22 |
| Sanara Medtech Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Abbott | 1 | $16 |
| Covidien LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$27,291
- DAVINCI XI$1,500
- ECHELON FLEX Stapler$129
- EVICEL Fibrin Sealant (Human)$129
- STRATAFIX$129
- ENSEAL Product Family$129
- HARMONIC Product Family$129
- Saxenda$102
How this compares
$31,858 in reported general payments places this provider in the 90th percentile of 970 surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 22 | $430 |
| Esomeprazole Magnesium | 11 | $194 |
| Omeprazole | 17 | $98 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 42 | $96 |
Paid to pharmacies, not to this prescriber.
Other surgery in Wilmington
- William HopeWilmington$761K
- Mark MedleyWilmington$206K
- Kamran GoudarziWilmington$132K
- Zachary WilliamsWilmington$118K
- Jacob SchroderDurham$2.6M
- Samuel RossCharlotte$2.6M
- Jacob GreenbergDurham$1.3M
- Brant HenifordCharlotte$963K
- Vedra AugensteinCharlotte$789K
- John MartinieCharlotte$712K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.